FRIDAY TOUR 4

LIPID/CARDIOVASCULAR DISORDERS/HYPERTENSION-OBESITY-REPRODUCTIVE
Poster Number Author Name Title
Merrell Magelli EFFECT OF TESTOSTERONE (T) REPLACEMENT WITH A T-GEL OR A NEW ORAL T FORMULATION (REXTORO) ON SELECTED BIOMARKERS OF ENDOTHELIAL INJURY AND IMMUNE RESPONSE TO LIPIDS
419 Dhruvi Hasnani ANALYSING ENDOTHELIAL DYSFUNCTION IN TYPE2 DIABETES MELLITUS PATIENTS USING FLOW MEDIATED DILATATION SCORE.
610 Ronette Kolotkin IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE WITH LIRAGLUTIDE 3.0 MG COMPARED WITH PLACEBO FOR WEIGHT MANAGEMENT
611 Michael Lean THE IMPACT OF GASTROINTESTINAL ADVERSE EVENTS ON WEIGHT LOSS WITH LIRAGLUTIDE 3.0 MG AS ADJUNCT TO A DIET AND EXERCISE PROGRAM
612 Jamy Ard EFFICACY AND SAFETY OF LIRAGLUTIDE 3.0 MG FOR WEIGHT MANAGEMENT ARE SIMILAR ACROSS RACE
913 Diane Check A SECOND CASE OF SUCCESSFUL CONCEPTION IN A NATURAL CYCLE DESPITE A MAXIMUM ENDOMETRIAL THICKNESS IN THE LATE FOLLICULAR PHASE OF 4MM
914 Kelly Cook ESTABLISHED RISK FACTORS AND NOT TESTOSTERONE THERAPY IN ITSELF IS ASSOCIATED WITH INCREASED MYOCARDIAL INFARCTION IN HEALTHY YOUNGER MEN: THE LOW T EXPERIENCE
915 Merrell Magelli EFFECT OF ONE-YEAR TESTOSTERONE REPLACEMENT WITH AN ORAL TESTOSTERONE (T) FORMULATION (REXTORO) OR A T-GEL (ANDROGEL) PREPARATION ON THE CARDIOVASCULAR BIOMARKERS C REACTIVE PROTEIN (HSCRP) AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LPPLA2)